Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

i_opioidsubstance_2017a_2017-10-23t09:32:09z4 Hearing Summary

Date: 10/23/2017

Location: RM 271


BILL SUMMARY for Bill Discussion - Bill 3


Votes: View--> Action Taken:
<none> <none>

03:46 PM -- Bill Discussion - Bill 3

Christy Chase, representing the Office of Legislative Legal Services, explained Bill 3 to the committee (Attachment U). The bill:


- excludes supervised injection facilities from the laws regarding public nuisance;

- allows local public health agencies to establish clean syringe exchange programs without prior approval from their governing health boards and grants civil immunity to a person who provides a clean syringe in accordance with a clean syringe exchange program;

- specifies that hospitals may be used as clean syringe exchange sites;

- allows school districts and nonpublic schools to develop a policy by which schools are allowed to obtain a supply of opiate antagonists and school employees are trained to administer opiate antagonists to individuals at risk of experiencing a drug overdose; and

- increases the criminal penalties related to synthetic opioids.

04:13 PM --
Adeline Hodge, representing the Colorado Association of School Nurses, the Colorado Providers Association, and the Colorado Association of Local Public Health Officials, testified in a neutral capacity.

04:17 PM --
Maureen Cain, representing the Colorado State Public Defender's Office, testified in a neutral capacity.

04:30 PM --
Christie Donner, representing Colorado Criminal Justice Reform Coalition, testified in a neutral capacity.

04:35 PM

Dr. Valuck testified in support of Bill 5 and Bill 6. He expressed that there is a significant need for in patient treatment.

04:38 PM --
Lisa Raville, representing the Harm Reduction Action Center, testified in support of supervised injection facilities and presented a handout (Attachment V). Ms. Raville answered questions from committee members about concerns regarding supervised injection sites.


04:56 PM -- Heidi Schlossberg, representing herself, testified in a neutral capacity.

04:57 PM --
Angela Bonaguidi, representing the Colorado Organization for the Treatment of Opioid Dependence, testified in a neutral capacity and distributed a handout (Attachment W).


04:59 PM -- Jamie Feld, representing Boulder County Public Health, testified in a neutral capacity. Ms. Feld responded to committee questions regarding naloxone in public schools.

05:10 PM --
Meghan Dollar, representing the Colorado Municipal League, testified in a neutral capacity and expressed concern regarding local control of proposed injection sites.

05:12 PM --
Frank Cornelia, representing the Colorado Behavioral Health Council, testified in a neutral capacity. Mr. Cornelia responded to questions from committee members regarding incentives for pursuing treatment and increasing inpatient programs in Colorado.

05:18 PM --
Michael Miller, representing Young People in Recovery, testified in a neutral capacity and expressed support for safe injections sites and other harm reduction measures.

Colorado legislature email addresses ending in are no longer active. Please replace with for Colorado legislature email addresses. Details

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details